![[Feedback]](/icons/banner/feedbackACT.gif){kind=icon}
![[For Subscribers]](/icons/banner/subscriberACT.gif){kind=icon}
![[Archive]](/icons/banner/archiveACT.gif){kind=icon}
![[Search]](/icons/banner/searchACT.gif){kind=icon}
![[Contents]](/icons/banner/tocACT.gif){kind=icon}
|
|
|
|
|
||
JU Adams, RJ Tallarida, EB Geller and MW Adler
Department of Pharmacology, Temple University School of Medicine, Philadelphia, Pennsylvania.
The present study was designed to test rigorously, using isobolographic analysis, whether there was a potentiative interaction between delta and mu agonists administered i.c.v. to rats. Factors such as the specific fixed ratio of compounds, the analgesic assay and the mu agonist were varied to determine the generality of the results. Male rats were implanted with i.c.v. cannulas and were tested in the cold (- 3 degrees C) or hot (+50 degrees C) water tail-flick test. Full dose- effect curves were generated for the mu agonists, morphine and [N- MePhe3,D-Pro4]morphiceptin and the delta-selective agonist, DPDPE. Each agonist induced dose-related analgesia in the cold water test (ED50 values were 12, 0.79 and 75 micrograms, respectively). In the hot water test, morphine induced analgesia with an ED50 value of 4.4 micrograms, whereas DPDPE failed to produce a full effect at doses up to 200 micrograms. Full dose-effect curves were also generated for various fixed-ratio combinations of DPDPE and morphine in both analgesic assays. Fixed ratios were chosen such that the amount of DPDPE in each dose of the combinations tested was itself subanalgesic. The combination with 20% DPDPE and 80% morphine (by weight) was significantly superadditive in the cold water test as determined by isobolographic analysis, whereas a second combination of the same drugs (40% DPDPE) was not. However, in the hot water test, the 20% DPDPE combination was not superadditive and neither were two other combinations of DPDPE and morphine. No combination of DPDPE and [N- MePhe3,D-Pro4]morphiceplin differed significantly from additivity when tested in the cold water test.(ABSTRACT TRUNCATED AT 250 WORDS)
This article has been cited by other articles:
|
|
 |
|
  G. P. Do Carmo, R. Polt, E. J. Bilsky, K. C. Rice, and S. S. Negus Behavioral Pharmacology of the {micro}/{delta} Opioid Glycopeptide MMP2200 in Rhesus Monkeys J. Pharmacol. Exp. Ther., September 1, 2008; 326(3): 939 - 948. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. T. Sykes, S. R. White, R. W. Hurley, H. Mizoguchi, L. F. Tseng, and D. L. Hammond Mechanisms Responsible for the Enhanced Antinociceptive Effects of {micro}-Opioid Receptor Agonists in the Rostral Ventromedial Medulla of Male Rats with Persistent Inflammatory Pain J. Pharmacol. Exp. Ther., August 1, 2007; 322(2): 813 - 821. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. W. Stevenson, J. E. Folk, K. C. Rice, and S. S. Negus Interactions between {delta} and {micro} Opioid Agonists in Assays of Schedule-Controlled Responding, Thermal Nociception, Drug Self-Administration, and Drug versus Food Choice in Rhesus Monkeys: Studies with SNC80 [(+)-4-[({alpha}R)-{alpha}-((2S,5R)-4-Allyl-2,5-dimethyl-1-piperazinyl)-3-methoxybenzyl]-N,N-diethylbenzamide] and Heroin J. Pharmacol. Exp. Ther., July 1, 2005; 314(1): 221 - 231. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. W. Stevenson, J. E. Folk, D. C. Linsenmayer, K. C. Rice, and S. S. Negus Opioid Interactions in Rhesus Monkeys: Effects of {delta} + {micro} and {delta} + {kappa} Agonists on Schedule-Controlled Responding and Thermal Nociception J. Pharmacol. Exp. Ther., December 1, 2003; 307(3): 1054 - 1064. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. I Eger II, Y. Xing, M. Laster, J. Sonner, J. F. Antognini, and E. Carstens Halothane and Isoflurane Have Additive Minimum Alveolar Concentration (MAC) Effects in Rats Anesth. Analg., May 1, 2003; 96(5): 1350 - 1353. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. A. Bolan, R. J. Tallarida, and G. W. Pasternak Synergy between {micro} Opioid Ligands: Evidence for Functional Interactions among {micro} Opioid Receptor Subtypes J. Pharmacol. Exp. Ther., November 1, 2002; 303(2): 557 - 562. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Benamar, E. B. Geller, and M. W. Adler Role of the Nitric Oxide Pathway in kappa -Opioid-Induced Hypothermia in Rats J. Pharmacol. Exp. Ther., October 1, 2002; 303(1): 375 - 378. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. M. Walker, L. C. Goudas, M. J. Cousins, and D. B. Carr Combination Spinal Analgesic Chemotherapy: A Systematic Review Anesth. Analg., September 1, 2002; 95(3): 674 - 715. [Full Text] [PDF]
|
|
|
|
|
|
R. J. Tallarida Drug Synergism: Its Detection and Applications J. Pharmacol. Exp. Ther., September 1, 2001; 298(3): 865 - 872. [Abstract] [Full Text]
|
|
|
|
 |
|
 R. W. Hurley and D. L. Hammond Contribution of Endogenous Enkephalins to the Enhanced Analgesic Effects of Supraspinal {micro} Opioid Receptor Agonists after Inflammatory Injury J. Neurosci., April 1, 2001; 21(7): 2536 - 2545. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. L. Fraser, A. A. Pradhan, P. B. S. Clarke, and C. Wahlestedt Supraspinal Antinociceptive Response to [D-Pen2,5]-Enkephalin (DPDPE) Is Pharmacologically Distinct from That to Other delta -Agonists in the Rat J. Pharmacol. Exp. Ther., December 1, 2000; 295(3): 1135 - 1141. [Abstract] [Full Text]
|
|
|
|
|
|
Y. A. Kolesnikov, I. Chereshnev, and G. W. Pasternak Analgesic Synergy between Topical Lidocaine and Topical Opioids J. Pharmacol. Exp. Ther., November 1, 2000; 295(2): 546 - 551. [Abstract] [Full Text]
|
|
|
|
|
|
R. W. Hurley and D. L. Hammond The Analgesic Effects of Supraspinal {micro} and delta Opioid Receptor Agonists Are Potentiated during Persistent Inflammation J. Neurosci., February 1, 2000; 20(3): 1249 - 1259. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. J. Tallarida, D. J. Stone Jr., J. D. McCary, and R. B. Raffa Response Surface Analysis of Synergism Between Morphine and Clonidine J. Pharmacol. Exp. Ther., April 1, 1999; 289(1): 8 - 13. [Abstract] [Full Text]
|
|
|
|
|
|
S. N. Thorat and D. L. Hammond Modulation of Nociception by Microinjection of Delta-1 and Delta-2 Opioid Receptor Ligands in the Ventromedial Medulla of the Rat J. Pharmacol. Exp. Ther., December 1, 1997; 283(3): 1185 - 1192. [Abstract] [Full Text]
|
|
|
|
|
|
R. E. Bartok and R. M. Craft Sex Differences in Opioid Antinociception J. Pharmacol. Exp. Ther., August 1, 1997; 282(2): 769 - 778. [Abstract] [Full Text]
|
|
|
|
|
|
L. Xin, E. B. Geller, L.-Y. Liu-Chen, C. Chen, and M. W. Adler Substance P Release in the Rat Periaqueductal Gray and Preoptic Anterior Hypothalamus after Noxious Cold Stimulation: Effect of Selective Mu and Kappa Opioid Agonists J. Pharmacol. Exp. Ther., August 1, 1997; 282(2): 1055 - 1063. [Abstract] [Full Text]
|
|
|
|
|
|
L. Xin, E. B. Geller, and M. W. Adler Body Temperature and Analgesic Effects of Selective Mu and Kappa Opioid Receptor Agonists Microdialyzed into Rat Brain J. Pharmacol. Exp. Ther., April 1, 1997; 281(1): 499 - 507. [Abstract] [Full Text]
|
|
|
|
|
|
J. S. Mogil and S. M. Adhikari Hot and Cold Nociception Are Genetically Correlated J. Neurosci., September 15, 1999; 19(18): RC25 - RC25. [Abstract] [Full Text] [PDF]
|
|
 |
 |
 |
|
 |
 |
 |
